Pooled Normal Human AB Serum Reference 6-9-14
Posted by Leanne Kodsman on
Innovative Research's Pooled Normal Human AB Serum was recently used in the following study:
Accepted Article Page 6. This article is protected by copyright. All rights reserved. in medium hereafter containing 10% human AB-serum (Innovative Research, Novi, MI, USA) instead of FCS, with no supplementary cytokines. Supernatants were...
Monocytederived dendritic cells from Crohn's disease patients exhibit decreased ability to activate Th17 responses in memory cells
JK Nieminen, T Sipponen, M Frkkil, O Vaarala - Clinical & Experimental , 2014Accepted Article Page 6. This article is protected by copyright. All rights reserved. in medium hereafter containing 10% human AB-serum (Innovative Research, Novi, MI, USA) instead of FCS, with no supplementary cytokines. Supernatants were...
The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!
Related Posts
Top 5 Biologicals to Buy Right Now
Innovative Research is excited to share our top 5 biological products that are making w...
Read the ArticleInnovative Research’s Role in Developing a Zero-Gravity Versatile Sample Preparation Platform (VSPP)
The realm of space exploration continually seeks innovations that can enhance the safet...
Read the ArticleWe have biological products and research materials to assist with early phase next gen COVID vaccine research
This autumn, as clinical trials get underway to evaluate the effectiveness of the most ...
Read the Article